Yeah, I saw that one. But the cohort of patients it's talking about already have autoimmune issues and the focus is on the adjunctives.

I think there was another one talking about 50% of severe covid patients developing autoimmune antibodies, but with no idea if they will progress to a condition.

I was hoping to see some longterm studies from prior mRNA research. But it's my understanding that the longer research wasn't about inducing immune response but for trying to modify DNA to correct genetic conditions (which failed, but now crispr...).